Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00728338 · ClinicalTrials.gov registry record · NA
Docosahexenoic Acid (DHA) Supplementation and Cardiovascular Disease in Men With High Triglycerides
A NA study, sponsored by USDA, Western Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00728338 is a NA study that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 40 participants.
The verdict
NCT00728338, a NA study, has completed, sponsored by USDA, Western Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of supplementing diets of hyperlipidemic men with DHA (docosahexenoic acid) on risk factors for cardiovascular disease. We hypothesize that supplementing diets of hyperlipidemic men with DHA will decrease the plasma concentrations of CRP (C-reactive protein), inflammatory cytokines, and soluble adhesion molecules. We further hypothesize that DHA supplementation will decrease serum triglyceride concentrations and increase HDL concentration.
Interventions
- DIETARY_SUPPLEMENT Olive oil
- DIETARY_SUPPLEMENT Docosahexenoic acid (DHA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2003-06 |
| Est. Completion | 2005-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00728338
The ClinicalTrials.gov registry entry for NCT00728338 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USDA, Western Human Nutrition Research Center, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Olive oil is the first listed.
NCT00728338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00728338 about?
NCT00728338 is a clinical study titled "Docosahexenoic Acid (DHA) Supplementation and Cardiovascular Disease in Men With High Triglycerides". The purpose of this study is to determine the effects of supplementing diets of hyperlipidemic men with DHA (docosahexenoic acid) on risk factors for cardiovascular disease. We hypothesize that supplementing diets of hyperlipidemic men with DHA will decrease the plasma concentrations of CRP (C-react...
What is the current status of trial NCT00728338?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2003-06. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00728338?
The interventions under investigation include: Olive oil (DIETARY_SUPPLEMENT), Docosahexenoic acid (DHA) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00728338?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.